"Designing Growth Strategies is in our DNA"

Dialysis Market Size, Share & COVID-19 Impact Analysis, By Type (Products and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers & Hospitals and Home Care), and Regional Forecast, 2023-2030

Region : Global | Format: PDF | Report ID: FBI102367



Play Audio Listen to Audio Version

The dialysis market size was USD 94.43 billion in 2022 and is projected to grow from USD 95.22 billion in 2023 to USD 150.84 billion by 2030, exhibiting a CAGR of 6.8% during 2023-2030. North America dominated the global market with a share of 40.72% in 2022.

The prevalence of chronic kidney diseases is rising at a significant rate, which in turn, has increased patient visits to renal therapy clinics over the last decade. Rise in the number of patients opting for this treatment have increased the demand for products, such as dialysate and hemodialysis machines. As a result of this, key companies are launching new products in the market and expanding their services, thereby accelerating the market growth during the forecast period.

  • For instance, in May 2022, Diaverum announced the acquisition of booknowmed.com, the world’s leading renal care booking website that allows patients to browse through over 400 dialysis clinics across 54 countries.

  • Similarly, in September 2022, Terumo Corporation received approval from the National Medical Products Administration (NMPA), China for its peritoneal dialysis solution.

Such new product launches and the rising prevalence of renal failure and other chronic diseases are expected to increase the patient population seeking this treatment, thereby spurring the market growth.


Market Growth Slowed Due to Decreased Number of ESRD Patients

The COVID-19 pandemic slowed the growth of the global market. Key firms reported single digit growth in revenues from their dialysis products and services owing to a slight increase in the number of patients requiring this treatment during the COVID-19 outbreak.

  • For instance, Baxter’s renal care segment witnessed a 3.2% increase in its revenue in 2020 as compared to the previous year and was valued at USD 3,757 million. This growth was attributed to the increased number of peritoneal dialysis patients across the globe.

Moreover, according to the U.S. Renal Data System population data, the number of ESRD patients decreased by 0.6% in the first year of the onset of the pandemic. This figure is expected to decline by 3.5% from the forecasted number as compared to the pre-pandemic data. Hence, the market recorded a comparatively lower growth rate in 2021 and 2022. Also, the market is anticipated to witness slower growth in 2023. However, with the increasing number of patients and growth rate expected to reach pre-pandemic level, the market might witness significant growth in the coming years.


Substantial Shift From In-Center Dialysis to Home Dialysis Identified As Significant Market Trend

Patients with End-Stage Renal Disease (ESRD) are required to undergo treatment at renal facilities or they can opt for these services at home. Rising preference of patients for receiving care at home, especially in the developed economies, is one of the key global market trends. Patients opting for at-home hemodialysis are expected to lead more independent lives and may have better chances of survival as compared to those treated at a center. Several studies have demonstrated the improvement in mortality rates in patients receiving hemodialysis at home than those treated at a medical center. Such benefits are expected to increase the adoption of these products in homecare settings.

  • For instance, according to an article published by the American Society of Nephrology in November 2021, the use of home dialysis had increased from 14.8% in 2016 to 20% in 2021 among patients with End-Stage Kidney Disease (ESKD).

Also, governments in nations, such as the U.S. are engaged in setting up new payment methods to make kidney disease treatments more affordable and accessible, which can increase the preference for low-cost care at home. This factor is estimated to boost the number of patients opting for treatment in homecare settings in the coming years.

Request a Free sample to learn more about this report.


Rising Prevalence of Chronic Kidney Diseases to Augment Market Growth

The overall burden of ESRD and CKD is one of the highest in terms of healthcare cost. Rising prevalence of chronic kidney diseases and renal failure, coupled with the increasing comorbidity of diabetes and hypertension in a patient, is one of the key factors bolstering this market’s growth. ESRD is the stage when one or both the kidneys permanently stop working properly and the patient needs to undergo long-term renal infusion therapy or receive a kidney transplant. Thus, the rising prevalence of ESRD is increasing the global cost burden of kidney diseases and is one of the key factors increasing the revenue of leading market players.

  • For instance, according to the data provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD), in September 2021, approximately 786,000 people in the U.S. were living with End-Stage Renal Disease (ESRD), out of which 71% were on dialysis.

  • Similarly, according to the 2022 annual report of Fresenius Medical Care, the number of chronic kidney failures across the globe was around 4.8 million in 2022. This number is expected to increase by 3-6% every year.

Furthermore, regulatory authorities are providing approval for the introduction of new products and consumables. Public authorities are increasing their participation to prevent & control renal diseases. Moreover, collaborations between various organizations to give efficient renal services in the niche areas of developing countries are estimated to further propel the dialysis market growth.

Improved Accessibility to Hemodialysis Centers to Drive Market Growth

The prevalence of chronic kidney diseases has increased considerably, which is propelling the demand for efficient renal facilities with lesser waiting time. The availability of well-qualified nephrologists in developed countries has, in turn, increased the number of renal care facilities. Moreover, to cater to the rising demand for renal care in emerging economies, investors are focusing more on increasing the network of renal treatment centers in countries, such as India, China, and Mexico. This is expected to increase the market’s revenue in the coming years. The delivery of affordable care in these countries is increasing the number of visits to these facilities.

  • For instance, in May 2023, Life Healthcare announced that it had acquired the operations of renal dialysis clinics of Fresenius Medical Care in Southern Africa. Through this acquisition, the company gained operational rights to 51 renal dialysis clinics, thereby expanding its services in the region.


Risks and Complications Associated with This Procedures to Slow Down Market Growth

Even though the number of patients receiving this treatment is constantly increasing, there are a few factors that may restrain the market growth over the forecast period. One of them is the risks and complications associated with these procedures.

Hemodialysis may cause severe complications and side-effects to patients undergoing this treatment. Several complications are associated with the creation of the access for this therapy. The imbalance of fluids and electrolytes in the body impacts the heart function and blood pressure, resulting in serious complications.

  • For instance, according to a study published in BMC Nephrology in August 2020, risk factors for elderly hemodialysis patients include cardiovascular diseases, type of the access, therapy initiation time, and others. Presence of other chronic diseases in the body further increases the risk of mortality in hemodialysis patients.

Few of the acute complications observed in hemodialysis patients include intradialytic hypotension or hypertension, cardiac arrhythmias, dialysis disequilibrium syndrome, seizures, bleeding, and others.


By Type Analysis

Dialysis Services Gained Momentum Owing to Increasing Prevalence of Chronic Kidney Diseases

Based on type, the market is segmented into products and services.

The services segment accounted for the maximum market share in 2022 due to the emergence of well-equipped renal care facilities for chronic and acute care across the globe and rising burden of kidney diseases. Due to these factors, the demand for chronic and acute-dialysis services has surged significantly.

  • For instance, according to the data published by the European Parliament in February 2022, around 100 million people in Europe were suffering from kidney diseases. Patients suffering from these ailments require dialysis to support their kidney health. The increasing prevalence of kidney diseases will increase awareness about the availability of dialysis services, thereby supporting the segment's growth.

Moreover, the products segment is expected to witness healthy growth in the coming years owing to the rising number of local and regional market players to cater to the growing demand for advanced products and consumables.

  • For instance, in February 2020, Fist Assist Devices LLC received the CE Mark and began marketing its Fist Assist device for vein enlargement in the European Union and other CE Mark countries. This device increases the vein diameter before fistula placement and assists in fistula vein dilation for hemodialysis in End-Stage Renal Disease (ESRD) patients.

To know how our report can help streamline your business, Speak to Analyst

By Dialysis Type Analysis

Hemodialysis to Gain Traction Owing to Higher Adoption of This Modality

By dialysis type, the global market is categorized into hemodialysis and peritoneal dialysis.

Hemodialysis segment generated the highest revenue in the market in 2022 and is expected to remain dominant in terms of revenue throughout the forecast period.  Inadequate training provided for peritoneal treatment in developed as well as developing countries has reduced the preference for peritoneal dialysis. Moreover, the clinical benefits associated with hemodialysis, such as lesser time and adoption of arteriovenous (AV) fistula are propelling the demand for this procedure.  Additionally, the increasing incidence of severe CKD among the geriatric population is augmenting the number of patients requiring hemodialysis treatment.

  • For instance, according to an article published in the Journal of Nephrology in September 2020, the incidence rate of stage IV CKD increases with age, hence the demand for hemodialysis treatment is growing.

The peritoneal dialysis segment is expected to witness strong growth over the forecast period. Increase in the preference for peritoneal dialysis over hemodialysis in developed countries is expected to drive the segment's growth during the forecast period. Additionally, demand for at-home peritoneal dialysis treatment is expected to increase in the coming years, thereby accelerating the segment’s growth.

  • For instance, according to data published by the NCBI in June 2022, Peritoneal Dialysis (PD) offers numerous benefits over hemodialysis (HD) including cost-effectiveness, increased patient independence, better quality of life, and preservation of residual kidney function, thereby increasing its adoption.

By End User Analysis

Dialysis Centers & Hospitals to Increase Product Use Owing to Rising Number of Patients Requiring Renal Care

Based on end-user, the market is segmented into dialysis centers & hospitals and home care.

 In terms of value, the dialysis center & hospital segment accounted for the largest market share in 2022. This is due to factors, such as favorable reimbursements provided by renal facilities & hospitals for renal therapies, rising number of patients suffering from CKD & ESRD, and increasing healthcare expenditure by the population. The segment is also expected to dominate the market throughout the forecast period.

  • For instance, in January 2023, six dialysis centers in the UAE’s Al Dhafra region upgraded their services by installing the latest medical equipment and hiring professionally trained medical staff. These factors will increase the number of patients served by the dialysis centers, further driving the segment’s growth.

Homecare is anticipated to be the fastest-growing segment during the forecast period, recording a considerable CAGR. The growth of this segment is attributed to the fact that homecare dialysis is a cost-effective therapy to treat End-Stage Kidney Disease (ESKD). Similarly, the launch of next-generation products for home dialysis will further augment the segment’s growth during the forecast period.

  • In June 2021, Baxter launched the next-generation Sharesource Analytics 1.0, a digital health module to enhance the clinical management of home-based Peritoneal Dialysis (PD) patients.


On the basis of region, the global market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America Dialysis Market Size, 2022 (USD Billion)

To get more information on the regional analysis of this market, Request a Free sample

North America accounted for a dominant part in the dialysis market share and generated a revenue of USD 38.46 billion in 2022. The region is projected to dominate the market during the forecast period as well. High prevalence of CKD and ESRD in the U.S. and Canada and a higher treatment rate in these countries are the key factors estimated to boost the expansion of the regional market during the forecast period. The U.S. is also projected to witness growth in the demand for dialysis services and products due to the increasing incidence of coronavirus infections that may cause renal failure in some infected patients.

  • According to an article published by the U.S. National Institutes of Health (NIH) in September 2021, 1 in 7 adults, which is an estimated 786,000 people, in the U.S. were living with end-stage kidney disease.

Europe is expected to emerge as the second-largest region in this market in terms of size, recording moderate growth in the long run. The region’s robust growth is due to the increasing percentage of the geriatric population suffering from renal disorders. Additionally, the number of patients receiving any form of dialysis therapy has increased over time throughout the region.

  • According to data published by the NCBI in November 2022, an estimated 46,813 patients were on dialysis treatment in Italy. Both hemodialysis (HD) and Peritoneal Dialysis (PD) therapies provided by renal care units in public hospitals/structures are free of cost to Italian citizens.

Moreover, Asia Pacific is expected to witness relatively higher growth in the global market. Funding by public organizations to improve the accessibility of renal care is likely to augment the regional market’s expansion during the forecast period. Also, the increasing accessibility of dialysis services in various regions including remote areas of Asia Pacific countries will further propel the market growth.

  • For instance, in March 2022, the Sathyalok free dialysis center was launched with the installation of 10 dialysis machines. The launch was funded by the Rotary Club of Chennai. This facility offered free dialysis to 18,000 people in 2022.

Furthermore, Latin America is expected to witness strong growth over the forecast period. In Brazil, the rising incidence of CKD among the elderly population is boosting the adoption of dialysis products and services.

  • For instance, the number of patients on dialysis in Brazil was 148,363 as per the Brazilian Dialysis Survey published in July 2021. This number was higher by 2.5% as compared to that in July 2020.

The Middle East & Africa is estimated to reflect significant growth during the forecast period due to the delayed diagnosis of chronic CKD and ESRD, and growing presence of key players in this region to offer innovative products and services.

  • For instance, in May 2023, Rockwell Medical, Inc. collaborated with Global Medical Supply Chain LLC for the distribution of Rockwell's hemodialysis concentrate products in the UAE.


Diligent Efforts by Leading Companies to Introduce Novel Products Strengthened Their Market Position

The market’s competitive landscape is semi-consolidated, with key players, such as Fresenius Medical Care, DaVita Inc., and Baxter capturing a significant share in 2022. These companies are adopting various strategies, such as focus on getting regulatory approvals and expansion of geographic presence through partnerships & collaborations to expand their customer base.

  • For instance, in April 2022, Fresenius Medical Care North America received the U.S. FDA 510(k) clearance for its VersiPD Cycler System, which is a portable automated peritoneal dialysis system.

  • Similarly, in July 2020, Baxter announced a partnership0020with Ayogo Health Inc. to provide digital health solutions for home dialysis. The aim of this strategic partnership was to deliver advanced digital health solutions that train and empower patients with kidney failure.

Apart from these players, other prominent companies, such as B. Braun SE, Medtronic, Asahi Kasei Medical Co., Ltd., and others are also undertaking various strategic initiatives, such as launch of new & innovative products and increasing R&D expenditure to strengthen their market presence.

  • For instance, in March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a company that prepares dialysis concentrates. With this acquisition, Intermedt’s product portfolio was permanently integrated into B. Braun's comprehensive range of products and services for dialysis therapy.



  • June 2023:  NephroPlus, an Indian dialysis service provider, introduced an innovative container dialysis unit in collaboration with Shri Vamshi Hospital. This launch was aimed at providing real-time monitoring, consultation, and other related services to dialysis patients.

  • June 2023: Rockwell Medical, Inc. and B. Braun Medical Inc. signed a three-year co-promotion services agreement. Through this agreement, B. Braun was designated as an independent, non-exclusive representative for the promotion of Rockwell’s hemodialysis concentrate products in the U.S.

  • May 2023: Life Healthcare announced that it had acquired the operations of renal dialysis clinics of Fresenius Medical Care in Southern Africa.

  • November 2022: Fresenius Medical Care North America announced that it had received the FDA clearance for its AquaA water purification system for hemodialysis.

  • March 2022: NIPRO announced the commercial launch of its SURDIAL DX Hemodialysis System in the U.S. The device was developed to offer patient-focused features for optimal performance, efficiency, and ergonomics.


An Infographic Representation of Dialysis Market

To get information on various segments, share your queries with us

The market report offers qualitative and quantitative insights on the products and services offered and a detailed analysis of the market’s size & growth rate for all possible segments. Along with this, the report provides an elaborative analysis of the market’s dynamics, emerging trends, and competitive landscape. Key insights offered in the report include the prevalence of CKD & ESRD in key countries, recent industry developments, such as partnerships, mergers & acquisitions, new product launches, reimbursement policies, regulatory scenario, and key industry trends.

Report Scope & Segmentation



Study Period


Base Year


Estimated Year 


Forecast Period


Historical Period


Growth Rate

CAGR of 6.8% from 2023-2030


Value (USD billion)


By Type

  • Products

  • Services

By Dialysis Type

  • Hemodialysis

  • Peritoneal Dialysis

By End-User

  • Dialysis Centers & Hospitals

  • Home Care

By Region

  • North America (By Type, By Dialysis Type, By End-User, By Country)

    • U.S.

    • Canada

  • Europe (By Type, By Dialysis Type, By End-User, By Country/Sub-Region)

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Scandinavia

    • Rest of Europe

  • Asia Pacific (By Type, By Dialysis Type, By End-User, By Country/Sub-Region)

    • Japan

    • China

    • India

    • Australia

    • Southeast Asia

    • Rest of Asia Pacific

  • Latin America (By Type, By Dialysis Type, By End-User, By Country/Sub-Region)

    • Brazil

    • Mexico

    • Rest of Latin America

  • Middle East & Africa (By Type, By Dialysis Type, By End-User, By Country/Sub-Region)

    • South Africa

    • GCC

    • Rest of Middle East & Africa

Frequently Asked Questions

Fortune Business Insights says that the global market stood at USD 94.43 billion in 2022 and is projected to reach USD 150.84 billion by 2030.

In 2022, the market value stood at USD 38.46 billion.

The market will exhibit steady growth at a CAGR of 6.8% during the forecast period of 2023-2030.

Currently, the services segment was leading in the market by type.

Growing prevalence of chronic kidney diseases, introduction of technologically advanced products, and government initiatives offering increased access to dialysis are the key drivers of the market.

Fresenius Medical Care, Baxter, and DaVita Inc. are the major players operating in the market.

North America dominated the market in 2022.

Surge in the demand for effective treatment of chronic kidney diseases, increased adoption of technologically advanced systems, and a large patient population base are some of the factors expected to drive the adoption of these products.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Nov, 2023
  • 2022
  • 2019-2021
  • 142


  • $4850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.